Trientine

Trientine
Product Description

Trientinen is indicated for the treatment of  patients with Wilson's disease who are intolerant of penicillamine.

Biophore's Trientine: DMF Filed

Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator
Specifications
  • Selling Points
    Price; Product Features; Product Performance; Quality Service
  • Supplied from
    India
  • Measured In
    gram; kilogram

Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator

More Products from Biophore Pharma INC. (57)

  • Sincalide

    Product Sincalide

    Sincalide is an Diagnostic Agent indicated To stimulate gallbladder, pancreatic secretion, to accelerate the transit of a barium meal through the small bowel.


    Biophore's Sincalide: API Developed, Validations Planned in Q3 2016, DMF to be filed in Q1 2017.
  • Zofenopril

    Product Zofenopril

    Zofenopril is an Antihypertensive agent.

    Biophore's Zofenopril: USFDA approved manufacturing facility, US DMF Filed  [ # 026446 ].
  • Tipiracil

    Product Tipiracil

    Tipiracil is an Thymidine  phosphorylase inhibitor/nucleoside metabolic inhibitor used to treatment of metastatic colorectal cancer.
  • Trifluridine

    Product Trifluridine

    Trifluridine is an Antiviral agent indicated for the treatment of of primary kerato conjunctivitis and recurrent epithelial keratitis.
  • DOTA

    Product DOTA

    DOTA is an Chelating agent

    Biophore's DOTA:   All impurities below 0.07 (% w/w), Stringent control on sodium and chloride, Stable at room temperature, Commercialized product for Europe.
  • DTPA

    Product DTPA

    DTPA is an Chelating agent

    Biophore's DTPA: Stringent control on Iron content,  All impurities below 0.01
  • Aviptadil
  • Benserazide
  • Carfilzomib
  • Cladribine
  • Cyclen
  • Elagolix

Biophore Pharma INC. resources (1)